Clinical Trials Logo

Clinical Trial Details — Status: Withdrawn

Administrative data

NCT number NCT02086760
Other study ID # 5580
Secondary ID
Status Withdrawn
Phase N/A
First received February 18, 2014
Last updated October 1, 2015
Start date May 2014
Est. completion date November 2016

Study information

Verified date October 2015
Source University Hospital, Strasbourg, France
Contact n/a
Is FDA regulated No
Health authority France: Agence Nationale de Sécurité du Médicament et des produits de santé
Study type Interventional

Clinical Trial Summary

Diagnosis and follow up of hydronephrosis is actually based on repeat ultrasonography and scintigraphy wich is a binding exam for children. We wanted to evaluate the use of ultrasonography sensibilized by an oral hydration and to determine its efficiency to detect which hydronephrosis need a surgery or not.


Recruitment information / eligibility

Status Withdrawn
Enrollment 0
Est. completion date November 2016
Est. primary completion date November 2016
Accepts healthy volunteers No
Gender Both
Age group N/A to 30 Days
Eligibility Inclusion Criteria:

- child of 30 days old or less

- unilateral or bilateral hydronephrosis (pelvis > 5mm )

Exclusion Criteria:

- complex uropathy

- diuretic administration 6 hours prior to ultrasonography or scintigraphy

- oral feeding trouble

Study Design

Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic


Related Conditions & MeSH terms


Intervention

Other:
Ultrasonography with oral hydration
Before, 30 min and 90 min following oral hydration
Radiation:
Scintigraphy


Locations

Country Name City State
France Service de Chirurgie Pédiatrique - Hôpital de Hautepierre- CHRU Strasbourg Strasbourg

Sponsors (1)

Lead Sponsor Collaborator
University Hospital, Strasbourg, France

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Similarity between the decision of the treating surgeon and the independent surgeon about the subject's medical care The primary outcome measure is a composite outcome measure consisting of multiple measures.
Indeed, the treating surgeon will make a decision (ie to operate or not) upon the clinical exam, ultrasonography with oral hydratation and scintigraphy results. The independent surgeon will only be given data from the clinical exam and the ultrasonography. For ultrasonography, the following parameters will be measured: cortical thickness, anteroposterior renal pelvis diameter, calyx diameter, kidney echogenicity, kidney size.
The measures will be done before, 30 min and 90 min following oral hydration.
For scintigraphy, the relative kidney function, T1/2, Tmax and NORA will be analyzed.
The result will be reported as a single value, ie:
the treating surgeon's decision and the independent surgeon's decision are similar (=1) or
the treating surgeon's decision and the independent surgeon's decision are not similar (=0)
V2 (Age of 6 months) No
Secondary Similarity between the decision of the treating surgeon and the independent surgeon about the subject's medical care The secondary outcome measure is a composite outcome measure consisting of multiple measures.
Indeed, the treating surgeon will make a decision (ie to operate or not) upon the clinical exam, ultrasonography with oral hydration and scintigraphy results. The independent surgeon will only be given data from the clinical exam and the ultrasonography with oral hydration, he will make a decision aposteriori.
For ultrasonography, the following parameters will be measured: cortical thickness, anteroposterior renal pelvis diameter, calyx diameter, kidney echogenicity, kidney size.
The measures will be done before, 30 min and 90 min following oral hydration.
For scintigraphy, the relative kidney function, T1/2, Tmax and NORA will be analyzed.
The result will be reported as a single value, ie:
the treating surgeon's decision and the independent surgeon's decision are similar (=1) or
the treating surgeon's decision and the independent surgeon's decision are not similar (=0)
Between V0 (age: 30 days ) and V2 (age: 6 months) No
See also
  Status Clinical Trial Phase
Active, not recruiting NCT05087537 - Effect of Concomitant Bladder Neck Incision and Urethral Valve Ablation on Surgical Re-intervention Rate for Patients With Posterior Urethral Valve N/A